Lupin gets US approval for colonoscopy prep drug, wins 180-day exclusivity

Lupin said it has received approval from the United States Food and Drug Administration (US FDA) for its abbreviated new drug application for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets, 1.479 g/0.225 g/0.188 g.​Read More